國立高雄大學圖資館 |

Language: English

Back

Pharmacological treatment of chronic...

Avanzas, Pablo.

Pharmacological treatment of chronic stable angina pectoris

Record Type:	Electronic resources : Monograph/item
Title/Author:	Pharmacological treatment of chronic stable angina pectorisedited by Pablo Avanzas, Juan Carlos Kaski.
other author:	Avanzas, Pablo.
Published:	Cham :Springer International Publishing :2015.
Description:	xi, 278 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Angina pectorisChemotherapy.
Online resource:	http://dx.doi.org/10.1007/978-3-319-17332-0
ISBN:	9783319173320 (electronic bk.)

Pharmacological treatment of chronic stable angina pectoris
Pharmacological treatment of chronic stable angina pectoris[electronic resource] /edited by Pablo Avanzas, Juan Carlos Kaski. - Cham :Springer International Publishing :2015. - xi, 278 p. :ill., digital ;24 cm. - Current cardiovascular therapy. - Current cardiovascular therapy..

Mechanisms of angina -- An overview of treatment and guidelines - ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.

This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.

ISBN: 9783319173320 (electronic bk.)

Standard No.: 10.1007/978-3-319-17332-0doiSubjects--Topical Terms:

726970
Angina pectoris
--Chemotherapy.

LC Class. No.: RC684.C48

Dewey Class. No.: 616.122061

Pharmacological treatment of chronic stable angina pectoris
LDR:02703nmm a2200325 a 4500 001 471609
003 DE-He213
005 20160125134550.0
006 m d
007 cr nn 008maaau
008 160223s2015 gw s 0 eng d
020 $a 9783319173320 (electronic bk.)
020 $a 9783319173313 (paper)
024 7 $a 10.1007/978-3-319-17332-0 $2 doi
035 $a 978-3-319-17332-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC684.C48
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.122061 $2 23
090 $a RC684.C48 $b P536 2015
245 0 0 $a Pharmacological treatment of chronic stable angina pectoris $h [electronic resource] / $c edited by Pablo Avanzas, Juan Carlos Kaski.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xi, 278 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current cardiovascular therapy
505 0 $a Mechanisms of angina -- An overview of treatment and guidelines - ESC /ACC-AHA/ NICE -- Beta-blockers -- Calcium channel blockers -- Nitrates -- Nicorandil -- Ivabradine. Trimetazidine -- Ranolazine -- New antianginal drugs still not available for clinical use -- Medical therapy versus revascularization in the management of stable angina pectoris.
520 $a This book describes the clinical challenge currently posed by stable angina pectoris and provides guidance for those making clinical decisions regarding its pharmacological treatment. The importance of providing effective treatment is beyond dispute and this book deals with the most relevant aspects related to its pharmacological treatment. The pathogenesis of myocardial ischemia as the basis for rational treatment of angina is discussed thoroughly together with all major management goals including optimal symptom control and the secondary prevention of serious cardiovascular events. Pharmacological Treatment of Chronic Stable Angina Pectoris provides a clear description of the mechanisms of action and clinical indications of available anti-angina drugs and strategies for the use of novel pharmacological agents. It also includes a critical appraisal of the major management guidelines, which will assist the reader to interpret current evidence and provide the most appropriate forms of treatment. The ongoing controversy regarding medical therapy versus myocardial revascularization for the management of stable angina pectoris is also addressed. This eminently practical book will help guiding the reader through the complexities of the field and will be highly appreciated by clinicians, clinical cardiologists and cardiology trainees alike.
650 0 $a Angina pectoris $x Chemotherapy. $3 726970
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Cardiology. $3 273804
700 1 $a Avanzas, Pablo. $3 676373
700 1 $a Kaski, Juan Carlos. $3 569221
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Current cardiovascular therapy. $3 677459
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-17332-0
950 $a Medicine (Springer-11650)